Patents by Inventor Florian Colbatzky

Florian Colbatzky has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • New dihydropteridinones, processes for preparing them and their use as pharmaceutical compositions
    Publication number: 20040176380
    Abstract: The present invention relates to new dihydropteridinones of general formula (I) 1
    Type: Application
    Filed: February 26, 2003
    Publication date: September 9, 2004
    Applicant: Boehringer Ingelheim Pharma GmbH Co. KG
    Inventors: Matthias Hoffmann, Matthias Grauert, Trixi Brandl, Steffen Breitfelder, Christian Eickmeier, Martin Steegmaier, Gisela Schnapp, Anke Baum, Jens Juergen Quant, Flavio Solca, Florian Colbatzky
  • Prodrugs of 1-methyl-2-(4-amidinophenylaminomethyl)-benzimidazol-5-yl-carboxylic acid-(N-2-pyridyl-N-2-hydroxycarbonylethyl)-amide
    Publication number: 20040059118
    Abstract: The present invention relates to new compounds of general formula 1
    Type: Application
    Filed: July 31, 2003
    Publication date: March 25, 2004
    Applicant: Boehringer Ingelheim Pharma GmbH & Co. KG
    Inventors: Norbert Hauel, Florian Colbatzky, Ulrich Busch
  • Use of inhibitors of the EGFR-mediated signal transduction for the treatment of benign prostatic hyperplasia (BPH)/prostatic hypertrophy
    Publication number: 20030225079
    Abstract: The present invention relates to the use of specific EGF-receptor antagonists for preparing a pharmaceutical composition for the prevention and/or treatment of benign prostatic hyperplasia and/or prostatic hypertrophy, a method for the treatment or prevention of benign prostatic hyperplasia/prostatic hypertrophy comprising administering an EGF-receptor antagonist of groups (A), (B) or (C), described herein optionally in combination with known compounds for the treatment of benign prostatic hyperplasia/prostatic hypertrophy, as well as associated pharmaceutical compositions.
    Type: Application
    Filed: May 8, 2003
    Publication date: December 4, 2003
    Applicant: Boehringer Ingelheim Pharma GmbH & CO. KG
    Inventors: Thomas Singer, Stefan Platz, Florian Colbatzky